Po-Ren Hsueh

InstitutionNational Taiwan University Hospital
AddressTaipei
Taiwan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 43 Covid-19 publications, with a maximum of 7 publications in March 2020 and April 2020
    All Publications
    Bar chart showing 770 publications over 20 distinct years, with a maximum of 76 publications in 2011
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Lin CN, Chan KR, Ooi EE, Chiou MT, Hoang M, Hsueh PR, Ooi PT. Animal Coronavirus Diseases: Parallels with COVID-19 in Humans. Viruses. 2021 07 30; 13(8). PMID: 34452372.
      Citations: 2     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    2. Chien YC, Lee YL, Liu PY, Lu MC, Shao PL, Lu PL, Cheng SH, Lin CY, Wu TS, Yen MY, Wang LS, Liu CP, Lee WS, Shi ZY, Chen YS, Wang FD, Tseng SH, Chen YH, Sheng WH, Lee CM, Chen YH, Ko WC, Hsueh PR. National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017-2020. J Glob Antimicrob Resist. 2021 09; 26:308-316. PMID: 34289409.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    3. Lai CC, Chen CH, Wang CY, Chen KH, Wang YH, Hsueh PR. Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2021 07 15; 76(8):1962-1968. PMID: 33758946.
      Citations: 9     Fields:    Translation:Humans
    4. Lai CC, Ko WC, Chen CJ, Chen PY, Huang YC, Lee PI, Hsueh PR. COVID-19 vaccines and thrombosis with thrombocytopenia syndrome. Expert Rev Vaccines. 2021 08; 20(8):1027-1035. PMID: 34176415.
      Citations: 2     Fields:    Translation:Humans
    5. Lai CC, Chen IT, Chao CM, Lee PI, Ko WC, Hsueh PR. COVID-19 vaccines: concerns beyond protective efficacy and safety. Expert Rev Vaccines. 2021 08; 20(8):1013-1025. PMID: 34180347.
      Citations: 2     Fields:    Translation:HumansAnimals
    6. Lai CC, Chao CM, Hsueh PR. Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials. J Microbiol Immunol Infect. 2021 Oct; 54(5):767-775. PMID: 34253490.
      Citations: 1     Fields:    Translation:Humans
    7. Yen MY, Yen YF, Chen SY, Lee TI, Huang KH, Chan TC, Tung TH, Hsu LY, Chiu TY, Hsueh PR, King CC. Learning from the past: Taiwan's responses to COVID-19 versus SARS. Int J Infect Dis. 2021 Sep; 110:469-478. PMID: 34098099.
      Citations: 1     Fields:    Translation:HumansCells
    8. Tseng WP, Wu JL, Wu CC, Kuo KT, Lin CH, Chung MY, Lee YF, Yang BJ, Huang CH, Chen SY, Yu CJ, Chen SC, Hsueh PR. Seroprevalence Surveys for Anti-SARS-CoV-2 Antibody in Different Populations in Taiwan With Low Incidence of COVID-19 in 2020 and Severe Outbreaks of SARS in 2003. Front Immunol. 2021; 12:626609. PMID: 34084161.
      Citations:    Fields:    Translation:HumansPHPublic Health
    9. Lai CC, Chen SY, Ko WC, Hsueh PR. Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents. 2021 Apr; 57(4):106324. PMID: 33746045.
      Citations: 10     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    10. Lai CC, Chen SY, Yen MY, Lee PI, Ko WC, Hsueh PR. The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan: A database analysis. Travel Med Infect Dis. 2021 Mar-Apr; 40:101997. PMID: 33640476.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    11. Lin YC, Lee YL, Cheng CY, Tseng WP, Wu JL, Lin CH, Chung MY, Kang CM, Lee YF, Chen CP, Huang CH, Liu CE, Cheng SH, Chen SC, Chen SY, Hsueh PR. Multicenter evaluation of four immunoassays for the performance of early diagnosis of COVID-19 and assessment of antibody responses of patients with pneumonia in Taiwan. J Microbiol Immunol Infect. 2021 Oct; 54(5):816-829. PMID: 33676864.
      Citations: 1     Fields:    Translation:Humans
    12. Chen SY, Lee YL, Lin YC, Lee NY, Liao CH, Hung YP, Lu MC, Wu JL, Tseng WP, Lin CH, Chung MY, Kang CM, Lee YF, Lee TF, Cheng CY, Chen CP, Huang CH, Liu CE, Cheng SH, Ko WC, Hsueh PR, Chen SC. Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan. Emerg Microbes Infect. 2020 Dec; 9(1):2157-2168. PMID: 32940547.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    13. Lai CC, Chen SY, Yen MY, Lee PI, Ko WC, Hsueh PR. The impact of COVID-19 preventative measures on airborne/droplet-transmitted infectious diseases in Taiwan. J Infect. 2021 03; 82(3):e30-e31. PMID: 33249105.
      Citations: 3     Fields:    Translation:Humans
    14. Chen PL, Lee NY, Cia CT, Ko WC, Hsueh PR. A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs. Front Pharmacol. 2020; 11:584956. PMID: 33364959.
      Citations: 15     
    15. Lai CC, Yen MY, Lee PI, Hsueh PR. How to Keep COVID-19 at Bay: A Taiwanese Perspective. J Epidemiol Glob Health. 2021 03; 11(1):1-5. PMID: 33605120.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    16. Jing R, Kudinha T, Zhou ML, Xiao M, Wang H, Yang WH, Xu YC, Hsueh PR. Laboratory diagnosis of COVID-19 in China: A review of challenging cases and analysis. J Microbiol Immunol Infect. 2021 Feb; 54(1):17-26. PMID: 33153907.
      Citations:    Fields:    Translation:HumansPHPublic Health
    17. Lai CC, Wang JH, Hsueh PR. Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review. Int J Infect Dis. 2020 Dec; 101:314-322. PMID: 33045429.
      Citations: 52     Fields:    Translation:HumansPHPublic Health
    18. Yang CJ, Wei YJ, Chang HL, Chang PY, Tsai CC, Chen YH, Hsueh PR. Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review. J Microbiol Immunol Infect. 2021 Feb; 54(1):27-36. PMID: 33060041.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    19. Lan SH, Lai CC, Huang HT, Chang SP, Lu LC, Hsueh PR. Tocilizumab for severe COVID-19: a systematic review and meta-analysis. Int J Antimicrob Agents. 2020 Sep; 56(3):106103. PMID: 32712333.
      Citations: 52     Fields:    Translation:HumansCellsPHPublic Health
    20. Voss A, Coombs G, Unal S, Saginur R, Hsueh PR. Publishing in face of the COVID-19 pandemic. Int J Antimicrob Agents. 2020 Jul; 56(1):106081. PMID: 32674930.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    21. Wu JL, Tseng WP, Lin CH, Lee TF, Chung MY, Huang CH, Chen SY, Hsueh PR, Chen SC. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2. J Infect. 2020 Sep; 81(3):435-442. PMID: 32553841.
      Citations: 49     Fields:    Translation:HumansCellsPHPublic Health
    22. Lai CC, Wang CY, Ko WC, Hsueh PR. In vitro diagnostics of coronavirus disease 2019: Technologies and application. J Microbiol Immunol Infect. 2021 Apr; 54(2):164-174. PMID: 32513617.
      Citations: 27     Fields:    Translation:HumansPHPublic Health
    23. Jean SS, Hsueh PR. Old and re-purposed drugs for the treatment of COVID-19. Expert Rev Anti Infect Ther. 2020 09; 18(9):843-847. PMID: 32419524.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
    24. Lin YC, Cheng CY, Chen CP, Cheng SH, Chang SY, Hsueh PR. A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response. Int J Infect Dis. 2020 Jul; 96:464-466. PMID: 32470604.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    25. Lai CC, Wang CY, Hsueh PR. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020 Aug; 53(4):505-512. PMID: 32482366.
      Citations: 111     Fields:    Translation:HumansCellsPHPublic Health
    26. Lai CC, Ko WC, Lee PI, Jean SS, Hsueh PR. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents. 2020 Aug; 56(2):106024. PMID: 32450197.
      Citations: 78     Fields:    Translation:HumansCellsPHPublic Health
    27. Lai CC, Wang CY, Wang YH, Hsueh PR. Global coronavirus disease 2019: What has daily cumulative index taught us? Int J Antimicrob Agents. 2020 Jun; 55(6):106001. PMID: 32360230.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    28. Lee YL, Liao CH, Liu PY, Cheng CY, Chung MY, Liu CE, Chang SY, Hsueh PR. Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients. J Infect. 2020 08; 81(2):e55-e58. PMID: 32335168.
      Citations: 57     Fields:    Translation:HumansCellsPHPublic Health
    29. Lai CC, Wang JH, Ko WC, Yen MY, Lu MC, Lee CM, Hsueh PR. COVID-19 in long-term care facilities: An upcoming threat that cannot be ignored. J Microbiol Immunol Infect. 2020 Jun; 53(3):444-446. PMID: 32303483.
      Citations: 21     Fields:    Translation:HumansCellsPHPublic Health
    30. Yen MY, Schwartz J, King CC, Lee CM, Hsueh PR. Recommendations for protecting against and mitigating the COVID-19 pandemic in long-term care facilities. J Microbiol Immunol Infect. 2020 Jun; 53(3):447-453. PMID: 32303480.
      Citations: 17     Fields:    Translation:HumansCellsPHPublic Health
    31. Jean SS, Lee PI, Hsueh PR. Treatment options for COVID-19: The reality and challenges. J Microbiol Immunol Infect. 2020 Jun; 53(3):436-443. PMID: 32307245.
      Citations: 140     Fields:    Translation:HumansCellsPHPublic Health
    32. Sheng WH, Ko WC, Huang YC, Hsueh PR. SARS-CoV-2 and COVID-19. J Microbiol Immunol Infect. 2020 Jun; 53(3):363-364. PMID: 32303481.
      Citations: 4     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    33. Liao CH, Hung SC, Lee YT, Hung HC, Hsueh PR. How do we decide to de-isolate COVID-19 patients? J Microbiol Immunol Infect. 2020 Jun; 53(3):386-388. PMID: 32299784.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    34. Huang YC, Lee PI, Hsueh PR. Evolving reporting criteria of COVID-19 in Taiwan during the epidemic. J Microbiol Immunol Infect. 2020 Jun; 53(3):413-418. PMID: 32224117.
      Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
    35. Lai CC, Wang CY, Wang YH, Hsueh SC, Ko WC, Hsueh PR. Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. Int J Antimicrob Agents. 2020 Apr; 55(4):105946. PMID: 32199877.
      Citations: 107     Fields:    Translation:HumansCellsPHPublic Health
    36. Yen MY, Schwartz J, Chen SY, King CC, Yang GY, Hsueh PR. Interrupting COVID-19 transmission by implementing enhanced traffic control bundling: Implications for global prevention and control efforts. J Microbiol Immunol Infect. 2020 Jun; 53(3):377-380. PMID: 32205090.
      Citations: 35     Fields:    Translation:HumansCellsPHPublic Health
    37. Lee NY, Li CW, Tsai HP, Chen PL, Syue LS, Li MC, Tsai CS, Lo CL, Hsueh PR, Ko WC. A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic. J Microbiol Immunol Infect. 2020 Jun; 53(3):485-487. PMID: 32198005.
      Citations: 30     Fields:    Translation:HumansCellsPHPublic Health
    38. Raoult D, Hsueh PR, Stefani S, Rolain JM. COVID-19 Therapeutic and Prevention. Int J Antimicrob Agents. 2020 04; 55(4):105937. PMID: 32151714.
      Citations: 9     Fields:    Translation:HumansCellsPHPublic Health
    39. Ko WC, Rolain JM, Lee NY, Chen PL, Huang CT, Lee PI, Hsueh PR. Arguments in favour of remdesivir for treating SARS-CoV-2 infections. Int J Antimicrob Agents. 2020 04; 55(4):105933. PMID: 32147516.
      Citations: 121     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    40. Lai CC, Liu YH, Wang CY, Wang YH, Hsueh SC, Yen MY, Ko WC, Hsueh PR. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. J Microbiol Immunol Infect. 2020 Jun; 53(3):404-412. PMID: 32173241.
      Citations: 289     Fields:    Translation:HumansCellsPHPublic Health
    41. Lee PI, Hu YL, Chen PY, Huang YC, Hsueh PR. Are children less susceptible to COVID-19? J Microbiol Immunol Infect. 2020 Jun; 53(3):371-372. PMID: 32147409.
      Citations: 190     Fields:    Translation:HumansCellsPHPublic Health
    42. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020 Mar; 55(3):105924. PMID: 32081636.
      Citations: 1461     Fields:    Translation:HumansCellsPHPublic Health
    43. Lee PI, Hsueh PR. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. J Microbiol Immunol Infect. 2020 Jun; 53(3):365-367. PMID: 32035811.
      Citations: 95     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    Hsueh's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (549)
    Explore
    _
    Co-Authors (154)
    Explore
    _
    Similar People (60)
    Explore
    _